Shanghai Labway Clinical Laboratory Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -17.83% vs -19.91% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 558.33% vs -2,700.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "287.20",
          "val2": "349.50",
          "chgp": "-17.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.70",
          "val2": "14.20",
          "chgp": "186.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "3.30",
          "chgp": "-69.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "38.50",
          "val2": "-8.40",
          "chgp": "558.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.80%",
          "val2": "-23.70%",
          "chgp": "16.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.06% vs -60.17% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 39.02% vs -121.88% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,739.40",
          "val2": "1,671.60",
          "chgp": "4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.70",
          "val2": "-72.10",
          "chgp": "155.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.00",
          "val2": "8.50",
          "chgp": "29.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-45.30",
          "val2": "-11.10",
          "chgp": "-308.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-98.60",
          "val2": "-161.70",
          "chgp": "39.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-36.70%",
          "val2": "-93.00%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

287.20

349.50

-17.83%

Operating Profit (PBDIT) excl Other Income

40.70

14.20

186.62%

Interest

1.00

3.30

-69.70%

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

38.50

-8.40

558.33%

Operating Profit Margin (Excl OI)

141.80%

-23.70%

16.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -17.83% vs -19.91% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 558.33% vs -2,700.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,739.40

1,671.60

4.06%

Operating Profit (PBDIT) excl Other Income

39.70

-72.10

155.06%

Interest

11.00

8.50

29.41%

Exceptional Items

-45.30

-11.10

-308.11%

Consolidate Net Profit

-98.60

-161.70

39.02%

Operating Profit Margin (Excl OI)

-36.70%

-93.00%

5.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.06% vs -60.17% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 39.02% vs -121.88% in Dec 2023

All Annual Results